共 50 条
- [1] Enantiomer associations in the crystal structures of racemic and (2S,3R)-(-)-3-hydroxy-2(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one ACTA CHEMICA SCANDINAVICA, 1996, 50 (10): : 906 - 913
- [2] Preparation of (2S,3S)-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one by microbial conversion JOURNAL OF FERMENTATION AND BIOENGINEERING, 1996, 81 (06): : 534 - 537
- [3] 2,3-dihydro-1,5-benzothiazepin-4(5H)-one ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2006, 62 : O1831 - O1832
- [7] 3-[(Z)-Benzylidene]-2,3-dihydro-1,5-benzothiazepin-4(5H)-one ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O3061 - U1638
- [8] 3-(2-Methylbenzylidene)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O243 - U1272
- [9] Production of (S2,3S)-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one, a key intermediate for diltiazem synthesis, by Bakers' yeast-mediated reduction JOURNAL OF FERMENTATION AND BIOENGINEERING, 1997, 84 (03): : 195 - 199
- [10] Synthesis and reactivity of 2,3-dihydro-3-hydroxy-2-phenyl-1,5-benzothiazepin-4(5H)-one derivatives COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE II FASCICULE C-CHIMIE, 2001, 4 (12): : 925 - 931